eGain Corporation (LON:0IFM)
14.58
+0.13 (0.93%)
At close: Nov 4, 2025
eGain Revenue
In the fiscal year ending June 30, 2025, eGain had annual revenue of $88.43M USD, down -4.71%. eGain had revenue of $23.23M in the quarter ending June 30, 2025, with 3.44% growth.
Revenue
$88.43M
Revenue Growth
-4.71%
P/S Ratio
4.92
Revenue / Employee
$198.28K
Employees
446
Market Cap
317.76M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 88.43M | -4.37M | -4.71% |
| Jun 30, 2024 | 92.80M | -5.21M | -5.31% |
| Jun 30, 2023 | 98.01M | 6.06M | 6.59% |
| Jun 30, 2022 | 91.95M | 13.66M | 17.45% |
| Jun 30, 2021 | 78.29M | 5.56M | 7.64% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 43.13B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |